Mok Tony
莫树锦
Areas of Expertise
Professional Biography
Dr. Mok Tony is Medical Oncologist, Lung Cancer Center at Shenzhen United Family Hospital, Shenzhen. B.Med.Sc. and M.D., University of Alberta, Canada.
Education & Training
- B.Med.Sc. and M.D., University of Alberta, Canada
- Fellowship in Medical Oncology, Princess Margaret Hospital, Toronto, Canada
- Community oncology practice, Toronto, Canada (7 years) before returning to Hong Kong, China in 1996
Awards & Certifications
- Fellow, American Society of Clinical Oncology (FASCO)
- Fellow, Hong Kong Academy of Sciences
- BBS (Bronze Bauhinia Star) — Hong Kong Government honor
Leadership & Board Memberships
- Medical Oncologist, Lung Cancer Center, Shenzhen United Family Hospital
- Chairman, Department of Clinical Oncology, Chinese University of Hong Kong
- Past President, International Association for the Study of Lung Cancer (IASLC)
Pioneering Contributions
Designed and led the IPASS trial — the global landmark study establishing first-line gefitinib for EGFR-mutation-positive advanced lung cancer, defining the era of precision medicine in thoracic oncology
Served as Past President of IASLC — the most important lung cancer academic organization in the world
Research has defined current international practice standards for EGFR, ALK, and KRAS-driven NSCLC
International Patient Services
Full support for your journey to China
Medipath provides comprehensive support for international patients. Services include full English-speaking medical consultations, dedicated medical translation staff, and specialized assistance with medical visa applications to ensure a seamless healthcare journey.
English Consultations
Full English-speaking medical appointments
Medical Translation
Dedicated translation for all documentation
Visa Assistance
Medical visa application support